LHX vs TVRD · P/E 34, rev $5.88B vs rev $2.6M
L3Harris Technologies Inc (LHX) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. TVRD currently screens at market cap $0.
Not investment advice. Open the LHX and TVRD stock pages for the full models.
Not investment advice.